An experiment was conducted on a nine - year old citrus, Citrus limonia L. garden affected with citrus nematode Tylenchulus semipenetrans heavily to evaluate the biocontrol potential of Pseudomonas fluorescens, Trichoderma viride, T. harzianum and Pochonia chlamydosporia in the management of citrus nematode. The above bioagents were inoculated in talc formulation at a depth of 20-30 cm and 120 cm away from the trunk of the tree and compared with carbofuran 3G (100g/tree) as chemical check and untreated control. Observations were made on citrus nematode population and fruit yield one year after the delivery of the above test bioagents. The observations revealed that all the bioagents are effective to reduce the citrus nematode population and to increase the fruit yield of Citrus limonia L. Among them the use of P. fluorescens available commercially as talc formulation @ 20g/tree is most effective to reduce T. semipenetrans population (71.49 %) and to increase the fruit yield three fold compared to untreated control.
Functional improvement following traumatic spinal cord injury (SCI) remains limited, therefore, it is necessary to develop therapeutic interventions such as cell transplantation to replace lost cells and promote connectivity. While transplantation typically focuses on neurons, it is important to include other neural cells, such as immature astrocytes, to provide a permissive environment, promote neuroprotection and regeneration, and ultimately restore connectivity. In this study, we leveraged cellular engineering using human induced pluripotent stem cells (hiPSCs) to generate astrocyte progenitor cells (hAPCs). We tested two hiPSC lines (WTC11 and KOLF2.1J) to characterize the fate of the hAPCs in vitro and following transplantation at the cervical level of the intact spinal cord for up to 3 weeks. Our results demonstrated efficient and consistent differentiation of the hiPSCs into hAPCs, their survival and integration with the adult spinal cord, with no signs of tumors, deleterious outcomes, and unexpected locations. The ability to survive and the absence of adverse effects indicate that hAPC transplantation could be a safe element of therapy in treating spinal cord injuries.